Valuation : Mesa Laboratories, Inc.

Market Cap 716M 617M 581M 529M 995M 67.91B 1B 6.86B 2.67B 34.54B 2.69B 2.63B 115B P/E 2027 *
57.9x
P/E 2028 * 38.3x
Enterprise Value 716M 617M 581M 529M 995M 67.91B 1B 6.86B 2.67B 34.54B 2.69B 2.63B 115B EV / Sales 2027 *
2.8x
EV / Sales 2028 * 2.65x
Free-Float
94.38%
Yield 2027 *
0.5%
Yield 2028 * 0.5%
1 day-2.08%
1 week-1.38%
Current month-1.78%
1 month+20.27%
3 months+19.32%
6 months+34.70%
Current year+59.99%
1 week 123.59
Extreme 123.59
129.66
1 month 93.03
Extreme 93.03
129.66
Current year 71.06
Extreme 71.065
129.66
1 year 58.83
Extreme 58.8337
129.66
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 57 2026-04-11
Director of Finance/CFO 58 2012-10-28
Comptroller/Controller/Auditor 41 2021-12-31
Director TitleAgeSince
Chairman 73 2017-08-31
Director/Board Member 58 2019-03-03
Director/Board Member 57 2020-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/15/26 Exercice

Director

5,568 0.0995%
8/15/26 Exercice

Director

5,568 0.0995%
8/15/26 Exercice

Chairman

5,568 0.0995%
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-1.38%+95.60%-10.56% 716M
-0.55%-5.61%-16.61%+6.58% 191B
+2.18%+1.57%-0.81%+12.71% 116B
+1.63%-0.06%+11.20%+87.39% 61.75B
-0.15%-0.96%-0.10%-32.50% 51.24B
+1.18%-0.02%+29.30%+54.07% 51.51B
-0.37%+1.66%+21.99%-11.05% 34.36B
+2.74%+0.76% - - 30.73B
-0.51%-2.64%+39.19%-16.78% 24.01B
+1.13%-1.96%-4.47%+15.32% 23.23B
Average +0.48%-0.93%+19.48%+11.69% 58.45B
Weighted average by Cap. +0.61%-1.92%+1.06%+15.92%

Financials

2027 *2028 *
Net sales 255M 220M 207M 189M 355M 24.23B 357M 2.45B 953M 12.33B 959M 938M 40.87B 270M 233M 219M 200M 376M 25.65B 378M 2.59B 1.01B 13.05B 1.01B 993M 43.26B
Net income 13.27M 11.44M 10.76M 9.81M 18.44M 1.26B 18.54M 127M 49.53M 640M 49.81M 48.73M 2.12B 21.13M 18.23M 17.15M 15.62M 29.38M 2.01B 29.54M 203M 78.9M 1.02B 79.35M 77.62M 3.38B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
26-09-01 US$125.80 -1.62% 49,408
26-08-31 US$127.87 -0.95% 155,878
26-08-28 US$129.09 +0.34% 153,083
26-08-27 US$128.65 +1.18% 158,261
26-08-26 US$127.15 -0.16% 110,866
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
127.87USD
Average target price
117.50USD
Spread / Average Target
-8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock